IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes
Despite SARS-CoV-2 being a “novel” virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing anti-spike IgG responses in non-hospitalized conva...
Gespeichert in:
Veröffentlicht in: | Cell reports (Cambridge) 2022-05, Vol.39 (9), p.110904-110904, Article 110904 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 110904 |
---|---|
container_issue | 9 |
container_start_page | 110904 |
container_title | Cell reports (Cambridge) |
container_volume | 39 |
creator | Garrido, Jose L. Medina, Matías A. Bravo, Felipe McGee, Sarah Fuentes-Villalobos, Francisco Calvo, Mario Pinos, Yazmin Bowman, James W. Bahl, Christopher D. Barria, Maria Ines Brachman, Rebecca A. Alvarez, Raymond A. |
description | Despite SARS-CoV-2 being a “novel” virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing anti-spike IgG responses in non-hospitalized convalescent individuals across a spectrum of COVID-19 severity. We observe that disease severity positively correlates with anti-spike IgG levels, IgG cross-reactivity against other betacoronaviruses (β-CoVs), and FcγR activation. Analysis of IgG targeting β-CoV-conserved and non-conserved immunodominant epitopes within the SARS-CoV-2 spike protein revealed epitope-specific relationships: IgG targeting the conserved heptad repeat (HR) 2 region significantly correlates with milder disease, while targeting the conserved S2′FP region correlates with more severe disease. Furthermore, a lower HR2-to-S2′FP IgG-binding ratio correlates with greater disease severity, with ICU-hospitalized COVID-19 patients showing the lowest HR2/S2′FP ratios. These findings suggest that HR2/S2′FP IgG profiles may predict disease severity and offer insight into protective versus deleterious humoral recall responses.
[Display omitted]
•COVID-19 severity correlates with FcγR activity and betacoronavirus cross-reactivity•IgG recall responses may be protective or deleterious, depending on epitope targeting•Conserved regions: targeting HR2 correlates with mild disease, S2′FP with severe disease•HR2-to-S2′FP IgG ratio may predict COVID-19 severity
Garrido et al. find that humoral memory responses against seasonal coronaviruses contribute to COVID-19 disease severity, conferring either protection or risk, depending on epitope targeting. These data suggest an explanatory mechanism underlying the atypical bimodality of COVID-19 disease severity, the observation of which was previously obscured by aggregate epitope analysis. |
doi_str_mv | 10.1016/j.celrep.2022.110904 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9108089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211124722006799</els_id><sourcerecordid>2671268523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-6fcf383613ae7b60baa270ed190cafacb4e3671d5c63f245318840310b86c7373</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EolXpGyDkI5csHjvrJBekaillpUqVKPRqOc5k6yWJF4-ziEfgrfFqSykXfPlteeb_x_4Yew1iAQL0u-3C4RBxt5BCygWAaET5jJ1KCVCALKvnT_Yn7JxoK_LSAqApX7ITtdRQNVqesl_rzRVPNm4w-WnDO09ZXeKElsJkB-5CzLr3caYiHybCuMeO3158vi1W4a6QnHb-G3Ka2y6M1k90aIk42ITEf_h0n037HiNOyWe_1c3d-kMBzSEqZyAPc3JhRHrFXvR2IDx_0DP29ePll9Wn4vrmar26uC5c2UAqdO96VSsNymLVatFaKyuBHTTC2d66tkSlK-iWTqtelksFdV0KBaKttatUpc7Y-6Pvbm5H7FyeK9rB7KIfbfxpgvXm35vJ35tN2JsGRC3qJhu8fTCI4fuMlMzoKeMY7IRhJiNzvNT1UqpcWh5LXQxEEfvHGBDmANJszRGkOYA0R5C57c3TER-b_mD7-wbMH7X3GA05j5PDzkd0yXTB_z_hNz9DsuI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671268523</pqid></control><display><type>article</type><title>IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Garrido, Jose L. ; Medina, Matías A. ; Bravo, Felipe ; McGee, Sarah ; Fuentes-Villalobos, Francisco ; Calvo, Mario ; Pinos, Yazmin ; Bowman, James W. ; Bahl, Christopher D. ; Barria, Maria Ines ; Brachman, Rebecca A. ; Alvarez, Raymond A.</creator><creatorcontrib>Garrido, Jose L. ; Medina, Matías A. ; Bravo, Felipe ; McGee, Sarah ; Fuentes-Villalobos, Francisco ; Calvo, Mario ; Pinos, Yazmin ; Bowman, James W. ; Bahl, Christopher D. ; Barria, Maria Ines ; Brachman, Rebecca A. ; Alvarez, Raymond A.</creatorcontrib><description>Despite SARS-CoV-2 being a “novel” virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing anti-spike IgG responses in non-hospitalized convalescent individuals across a spectrum of COVID-19 severity. We observe that disease severity positively correlates with anti-spike IgG levels, IgG cross-reactivity against other betacoronaviruses (β-CoVs), and FcγR activation. Analysis of IgG targeting β-CoV-conserved and non-conserved immunodominant epitopes within the SARS-CoV-2 spike protein revealed epitope-specific relationships: IgG targeting the conserved heptad repeat (HR) 2 region significantly correlates with milder disease, while targeting the conserved S2′FP region correlates with more severe disease. Furthermore, a lower HR2-to-S2′FP IgG-binding ratio correlates with greater disease severity, with ICU-hospitalized COVID-19 patients showing the lowest HR2/S2′FP ratios. These findings suggest that HR2/S2′FP IgG profiles may predict disease severity and offer insight into protective versus deleterious humoral recall responses.
[Display omitted]
•COVID-19 severity correlates with FcγR activity and betacoronavirus cross-reactivity•IgG recall responses may be protective or deleterious, depending on epitope targeting•Conserved regions: targeting HR2 correlates with mild disease, S2′FP with severe disease•HR2-to-S2′FP IgG ratio may predict COVID-19 severity
Garrido et al. find that humoral memory responses against seasonal coronaviruses contribute to COVID-19 disease severity, conferring either protection or risk, depending on epitope targeting. These data suggest an explanatory mechanism underlying the atypical bimodality of COVID-19 disease severity, the observation of which was previously obscured by aggregate epitope analysis.</description><identifier>ISSN: 2211-1247</identifier><identifier>EISSN: 2211-1247</identifier><identifier>DOI: 10.1016/j.celrep.2022.110904</identifier><identifier>PMID: 35617962</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ADE ; antibody-mediated effector responses ; COVID-19 ; disease severity ; Fc-gamma receptor activation ; fusion protein region ; heptad repeat region ; human betacoronavirus ; Humans ; Immunoglobulin G ; OC43 ; SARS-CoV-2 ; SARS1 ; Seasons ; Spike Glycoprotein, Coronavirus</subject><ispartof>Cell reports (Cambridge), 2022-05, Vol.39 (9), p.110904-110904, Article 110904</ispartof><rights>2022 The Author(s)</rights><rights>Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><rights>2022 The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-6fcf383613ae7b60baa270ed190cafacb4e3671d5c63f245318840310b86c7373</citedby><cites>FETCH-LOGICAL-c491t-6fcf383613ae7b60baa270ed190cafacb4e3671d5c63f245318840310b86c7373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,864,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35617962$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garrido, Jose L.</creatorcontrib><creatorcontrib>Medina, Matías A.</creatorcontrib><creatorcontrib>Bravo, Felipe</creatorcontrib><creatorcontrib>McGee, Sarah</creatorcontrib><creatorcontrib>Fuentes-Villalobos, Francisco</creatorcontrib><creatorcontrib>Calvo, Mario</creatorcontrib><creatorcontrib>Pinos, Yazmin</creatorcontrib><creatorcontrib>Bowman, James W.</creatorcontrib><creatorcontrib>Bahl, Christopher D.</creatorcontrib><creatorcontrib>Barria, Maria Ines</creatorcontrib><creatorcontrib>Brachman, Rebecca A.</creatorcontrib><creatorcontrib>Alvarez, Raymond A.</creatorcontrib><title>IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes</title><title>Cell reports (Cambridge)</title><addtitle>Cell Rep</addtitle><description>Despite SARS-CoV-2 being a “novel” virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing anti-spike IgG responses in non-hospitalized convalescent individuals across a spectrum of COVID-19 severity. We observe that disease severity positively correlates with anti-spike IgG levels, IgG cross-reactivity against other betacoronaviruses (β-CoVs), and FcγR activation. Analysis of IgG targeting β-CoV-conserved and non-conserved immunodominant epitopes within the SARS-CoV-2 spike protein revealed epitope-specific relationships: IgG targeting the conserved heptad repeat (HR) 2 region significantly correlates with milder disease, while targeting the conserved S2′FP region correlates with more severe disease. Furthermore, a lower HR2-to-S2′FP IgG-binding ratio correlates with greater disease severity, with ICU-hospitalized COVID-19 patients showing the lowest HR2/S2′FP ratios. These findings suggest that HR2/S2′FP IgG profiles may predict disease severity and offer insight into protective versus deleterious humoral recall responses.
[Display omitted]
•COVID-19 severity correlates with FcγR activity and betacoronavirus cross-reactivity•IgG recall responses may be protective or deleterious, depending on epitope targeting•Conserved regions: targeting HR2 correlates with mild disease, S2′FP with severe disease•HR2-to-S2′FP IgG ratio may predict COVID-19 severity
Garrido et al. find that humoral memory responses against seasonal coronaviruses contribute to COVID-19 disease severity, conferring either protection or risk, depending on epitope targeting. These data suggest an explanatory mechanism underlying the atypical bimodality of COVID-19 disease severity, the observation of which was previously obscured by aggregate epitope analysis.</description><subject>ADE</subject><subject>antibody-mediated effector responses</subject><subject>COVID-19</subject><subject>disease severity</subject><subject>Fc-gamma receptor activation</subject><subject>fusion protein region</subject><subject>heptad repeat region</subject><subject>human betacoronavirus</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>OC43</subject><subject>SARS-CoV-2</subject><subject>SARS1</subject><subject>Seasons</subject><subject>Spike Glycoprotein, Coronavirus</subject><issn>2211-1247</issn><issn>2211-1247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi0EolXpGyDkI5csHjvrJBekaillpUqVKPRqOc5k6yWJF4-ziEfgrfFqSykXfPlteeb_x_4Yew1iAQL0u-3C4RBxt5BCygWAaET5jJ1KCVCALKvnT_Yn7JxoK_LSAqApX7ITtdRQNVqesl_rzRVPNm4w-WnDO09ZXeKElsJkB-5CzLr3caYiHybCuMeO3158vi1W4a6QnHb-G3Ka2y6M1k90aIk42ITEf_h0n037HiNOyWe_1c3d-kMBzSEqZyAPc3JhRHrFXvR2IDx_0DP29ePll9Wn4vrmar26uC5c2UAqdO96VSsNymLVatFaKyuBHTTC2d66tkSlK-iWTqtelksFdV0KBaKttatUpc7Y-6Pvbm5H7FyeK9rB7KIfbfxpgvXm35vJ35tN2JsGRC3qJhu8fTCI4fuMlMzoKeMY7IRhJiNzvNT1UqpcWh5LXQxEEfvHGBDmANJszRGkOYA0R5C57c3TER-b_mD7-wbMH7X3GA05j5PDzkd0yXTB_z_hNz9DsuI</recordid><startdate>20220531</startdate><enddate>20220531</enddate><creator>Garrido, Jose L.</creator><creator>Medina, Matías A.</creator><creator>Bravo, Felipe</creator><creator>McGee, Sarah</creator><creator>Fuentes-Villalobos, Francisco</creator><creator>Calvo, Mario</creator><creator>Pinos, Yazmin</creator><creator>Bowman, James W.</creator><creator>Bahl, Christopher D.</creator><creator>Barria, Maria Ines</creator><creator>Brachman, Rebecca A.</creator><creator>Alvarez, Raymond A.</creator><general>Elsevier Inc</general><general>The Author(s)</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220531</creationdate><title>IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes</title><author>Garrido, Jose L. ; Medina, Matías A. ; Bravo, Felipe ; McGee, Sarah ; Fuentes-Villalobos, Francisco ; Calvo, Mario ; Pinos, Yazmin ; Bowman, James W. ; Bahl, Christopher D. ; Barria, Maria Ines ; Brachman, Rebecca A. ; Alvarez, Raymond A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-6fcf383613ae7b60baa270ed190cafacb4e3671d5c63f245318840310b86c7373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ADE</topic><topic>antibody-mediated effector responses</topic><topic>COVID-19</topic><topic>disease severity</topic><topic>Fc-gamma receptor activation</topic><topic>fusion protein region</topic><topic>heptad repeat region</topic><topic>human betacoronavirus</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>OC43</topic><topic>SARS-CoV-2</topic><topic>SARS1</topic><topic>Seasons</topic><topic>Spike Glycoprotein, Coronavirus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garrido, Jose L.</creatorcontrib><creatorcontrib>Medina, Matías A.</creatorcontrib><creatorcontrib>Bravo, Felipe</creatorcontrib><creatorcontrib>McGee, Sarah</creatorcontrib><creatorcontrib>Fuentes-Villalobos, Francisco</creatorcontrib><creatorcontrib>Calvo, Mario</creatorcontrib><creatorcontrib>Pinos, Yazmin</creatorcontrib><creatorcontrib>Bowman, James W.</creatorcontrib><creatorcontrib>Bahl, Christopher D.</creatorcontrib><creatorcontrib>Barria, Maria Ines</creatorcontrib><creatorcontrib>Brachman, Rebecca A.</creatorcontrib><creatorcontrib>Alvarez, Raymond A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell reports (Cambridge)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garrido, Jose L.</au><au>Medina, Matías A.</au><au>Bravo, Felipe</au><au>McGee, Sarah</au><au>Fuentes-Villalobos, Francisco</au><au>Calvo, Mario</au><au>Pinos, Yazmin</au><au>Bowman, James W.</au><au>Bahl, Christopher D.</au><au>Barria, Maria Ines</au><au>Brachman, Rebecca A.</au><au>Alvarez, Raymond A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes</atitle><jtitle>Cell reports (Cambridge)</jtitle><addtitle>Cell Rep</addtitle><date>2022-05-31</date><risdate>2022</risdate><volume>39</volume><issue>9</issue><spage>110904</spage><epage>110904</epage><pages>110904-110904</pages><artnum>110904</artnum><issn>2211-1247</issn><eissn>2211-1247</eissn><abstract>Despite SARS-CoV-2 being a “novel” virus, early detection of anti-spike IgG in severe COVID-19 patients may be caused by the amplification of humoral memory responses against seasonal coronaviruses. Here, we examine this phenomenon by characterizing anti-spike IgG responses in non-hospitalized convalescent individuals across a spectrum of COVID-19 severity. We observe that disease severity positively correlates with anti-spike IgG levels, IgG cross-reactivity against other betacoronaviruses (β-CoVs), and FcγR activation. Analysis of IgG targeting β-CoV-conserved and non-conserved immunodominant epitopes within the SARS-CoV-2 spike protein revealed epitope-specific relationships: IgG targeting the conserved heptad repeat (HR) 2 region significantly correlates with milder disease, while targeting the conserved S2′FP region correlates with more severe disease. Furthermore, a lower HR2-to-S2′FP IgG-binding ratio correlates with greater disease severity, with ICU-hospitalized COVID-19 patients showing the lowest HR2/S2′FP ratios. These findings suggest that HR2/S2′FP IgG profiles may predict disease severity and offer insight into protective versus deleterious humoral recall responses.
[Display omitted]
•COVID-19 severity correlates with FcγR activity and betacoronavirus cross-reactivity•IgG recall responses may be protective or deleterious, depending on epitope targeting•Conserved regions: targeting HR2 correlates with mild disease, S2′FP with severe disease•HR2-to-S2′FP IgG ratio may predict COVID-19 severity
Garrido et al. find that humoral memory responses against seasonal coronaviruses contribute to COVID-19 disease severity, conferring either protection or risk, depending on epitope targeting. These data suggest an explanatory mechanism underlying the atypical bimodality of COVID-19 disease severity, the observation of which was previously obscured by aggregate epitope analysis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35617962</pmid><doi>10.1016/j.celrep.2022.110904</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2211-1247 |
ispartof | Cell reports (Cambridge), 2022-05, Vol.39 (9), p.110904-110904, Article 110904 |
issn | 2211-1247 2211-1247 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9108089 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | ADE antibody-mediated effector responses COVID-19 disease severity Fc-gamma receptor activation fusion protein region heptad repeat region human betacoronavirus Humans Immunoglobulin G OC43 SARS-CoV-2 SARS1 Seasons Spike Glycoprotein, Coronavirus |
title | IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IgG%20targeting%20distinct%20seasonal%20coronavirus-%20conserved%20SARS-CoV-2%20spike%20subdomains%20correlates%20with%20differential%20COVID-19%20disease%20outcomes&rft.jtitle=Cell%20reports%20(Cambridge)&rft.au=Garrido,%20Jose%20L.&rft.date=2022-05-31&rft.volume=39&rft.issue=9&rft.spage=110904&rft.epage=110904&rft.pages=110904-110904&rft.artnum=110904&rft.issn=2211-1247&rft.eissn=2211-1247&rft_id=info:doi/10.1016/j.celrep.2022.110904&rft_dat=%3Cproquest_pubme%3E2671268523%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671268523&rft_id=info:pmid/35617962&rft_els_id=S2211124722006799&rfr_iscdi=true |